Andrew Katims
Overview
Explore the profile of Andrew Katims including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu A, Hensley P, Huelster H, Martin A, Potrezke A, Pham J, et al.
BJU Int
. 2025 Jan;
PMID: 39825642
Objectives: To evaluate the benefit of neoadjuvant chemotherapy (NAC) for patients with high-risk upper tract urothelial carcinoma (UTUC) using a large, well-curated multi-institutional database. Patients And Methods: This study was...
2.
Lenis A, Ravichandran V, Brown S, Alam S, Katims A, Truong H, et al.
Clin Cancer Res
. 2024 Jul;
30(17):3894-3903.
PMID: 38949888
Purpose: Patients with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) and high tumor mutational burden (TMB-H) prostate cancers are candidates for pembrolizumab. We define the genomic features, clinical course, and response to immune...
3.
Lenis A, Whiting K, Ravichandran V, Tallman J, Alam S, Chu C, et al.
JCO Precis Oncol
. 2024 May;
8:e2300274.
PMID: 38691813
Purpose: Patients with residual invasive bladder cancer after neoadjuvant chemotherapy (NAC) and radical cystectomy have a poor prognosis. Data on adjuvant therapy for these patients are conflicting. We sought to...
4.
Gaffney C, Katims A, DSouza N, Bjurlin M, Matulewicz R
Eur Urol Focus
. 2023 Apr;
9(4):575-578.
PMID: 37028984
Bladder cancer at an individual level is likely to be the consequence of repeated, long-term exposure to one or more known bladder carcinogens, some of which are endemic or unavoidable...
5.
Bieber C, Katims A, Ranti D, Sfakianos J, Amend G
Urol Case Rep
. 2022 Oct;
45:102236.
PMID: 36281436
Germ cell tumors (GCT) are rare, frequently diagnosed in men aged 20-34 years old, and have a 95% 5-year relative survival rate. Metastasis from GCT has predictable spread to retroperitoneal...
6.
Kenigsberg A, Carpinito G, Gold S, Meng X, Ghoreifi A, Djaladat H, et al.
Urol Oncol
. 2022 Aug;
40(10):452.e17-452.e23.
PMID: 35934609
Introduction: Perioperative intravesical chemotherapy (IVC) at or around the time of radical nephroureterectomy (RNU) reduces the risk of intravesical recurrence. Guidelines since 2013 have recommended its use. The objective of...
7.
Khaleel S, Katims A, Cumarasamy S, Rosenzweig S, Attalla K, Hakimi A, et al.
Cancers (Basel)
. 2022 May;
14(9).
PMID: 35565216
Radiogenomics is a field of translational radiology that aims to associate a disease's radiologic phenotype with its underlying genotype, thus offering a novel class of non-invasive biomarkers with diagnostic, prognostic,...
8.
Izadmehr S, Lundon D, Mohamed N, Katims A, Patel V, Eilender B, et al.
Front Oncol
. 2021 Oct;
11:734963.
PMID: 34646777
Coronavirus disease-2019 (COVID-19), a disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, has become an unprecedented global health emergency, with fatal outcomes among adults of all ages...
9.
Katims A, Rosen D, Chandhoke R, Gupta M
J Endourol Case Rep
. 2020 Aug;
6(1):42-44.
PMID: 32775673
Complete ureteral duplication is uncommon and occasionally associated with ureteral stone obstruction. Even rarer is ectopic insertion of a ureter into the urethra. We describe a case of a 75-year-old...
10.
Nahar B, Katims A, Barboza M, Prakash N, Venkatramani V, Kava B, et al.
Urology
. 2017 Aug;
110:134-139.
PMID: 28842208
Objectives: To evaluate the impact of adding magnetic resonance imaging-ultrasound (MRI-US) fusion biopsy cores to standard 12-core biopsy in selecting men for active surveillance (AS). Materials And Methods: Among men...